These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19323659)

  • 41. Hidradenitis suppurativa treated with Clostridium botulinum toxin A.
    Khoo AB; Burova EP
    Clin Exp Dermatol; 2014 Aug; 39(6):749-50. PubMed ID: 24986398
    [No Abstract]   [Full Text] [Related]  

  • 42. Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea.
    Cho M; Woo YR; Cho SH; Lee JD; Kim HS
    Acta Derm Venereol; 2023 Dec; 103():adv18392. PubMed ID: 38078688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Four-weekly infliximab in the treatment of severe hidradenitis suppurativa.
    Moriarty B; Jiyad Z; Creamer D
    Br J Dermatol; 2014 Apr; 170(4):986-7. PubMed ID: 24641123
    [No Abstract]   [Full Text] [Related]  

  • 44. Recalcitrant severe hidradenitis suppurativa successfully treated with cyclosporine A.
    Bianchi L; Hansel K; Stingeni L
    J Am Acad Dermatol; 2012 Dec; 67(6):e278-9. PubMed ID: 23158638
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of hidradenitis suppurativa in pregnancy.
    Perng P; Zampella JG; Okoye GA
    J Am Acad Dermatol; 2017 May; 76(5):979-989. PubMed ID: 28040373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hidradenitis suppurativa is treated with low-dose flutamide.
    Li C; Xu H; Zhang X; Zhang W; He Y; Wang B
    J Dermatol; 2019 Feb; 46(2):e52-e54. PubMed ID: 30076633
    [No Abstract]   [Full Text] [Related]  

  • 47. Ethics of diabetic drugs for weight loss in hidradenitis suppurativa patients.
    Katsetos M; Torre K; Grant-Kels JM
    J Am Acad Dermatol; 2024 Aug; 91(2):406-407. PubMed ID: 37558092
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of biologics in the treatment of hidradenitis suppurativa: a review of the Henry Ford Hospital experience.
    Zhang J; Reeder VJ; Hamzavi IH
    Br J Dermatol; 2014 Dec; 171(6):1600-2. PubMed ID: 24931223
    [No Abstract]   [Full Text] [Related]  

  • 49. Fumarates, a new treatment option for therapy-resistant hidradenitis suppurativa: a prospective open-label pilot study.
    Deckers IE; van der Zee HH; Balak DM; Prens EP
    Br J Dermatol; 2015 Mar; 172(3):828-9. PubMed ID: 25123023
    [No Abstract]   [Full Text] [Related]  

  • 50. Low-dose adalimumab biosimilar (ZRC-3197) in the treatment of hidradenitis suppurativa.
    Patil S
    Indian J Dermatol Venereol Leprol; 2018; 84(6):745-747. PubMed ID: 30289113
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of hidradenitis suppurativa: is oral isoniazid an option?
    Miller IM; Dufour DN; Jemec GB
    J Dermatolog Treat; 2012 Apr; 23(2):128-30. PubMed ID: 20964576
    [No Abstract]   [Full Text] [Related]  

  • 52. Azathioprine lacks efficacy in hidradenitis suppurativa: a retrospective study of nine patients.
    Nazary M; Prens EP; Boer J
    Br J Dermatol; 2016 Mar; 174(3):639-41. PubMed ID: 26285784
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy of intralesional photodynamic therapy for the treatment of hidradenitis suppurativa.
    Rodríguez-Prieto MÁ; Valladares-Narganes LM; González-Sixto B; Noguerol-Cal M
    J Am Acad Dermatol; 2013 May; 68(5):873-5. PubMed ID: 23602177
    [No Abstract]   [Full Text] [Related]  

  • 54. Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study.
    Tseng CH
    Dermatology; 2023; 239(4):542-552. PubMed ID: 36921584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ustekinumab for hidradenitis suppurativa: a case report.
    Santos-Pérez MI; García-Rodicio S; Del Olmo-Revuelto MA; Pozo-Román T
    Actas Dermosifiliogr; 2014 Sep; 105(7):720-2. PubMed ID: 24308927
    [No Abstract]   [Full Text] [Related]  

  • 56. A systematic review and critical appraisal of pharmacological treatments for pediatric hidradenitis suppurativa.
    Moreno A; Williams SC; Goto R; Krueger JG; Renert-Yuval Y
    J Am Acad Dermatol; 2023 Sep; 89(3):584-586. PubMed ID: 37164242
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.
    Delaunay J; Villani AP; Guillem P; Tristan A; Boibieux A; Jullien D
    Br J Dermatol; 2018 Jan; 178(1):e15-e16. PubMed ID: 28626900
    [No Abstract]   [Full Text] [Related]  

  • 58. Low-dose systemic corticosteroid treatment for recalcitrant hidradenitis suppurativa.
    Wong D; Walsh S; Alhusayen R
    J Am Acad Dermatol; 2016 Nov; 75(5):1059-1062. PubMed ID: 27745633
    [No Abstract]   [Full Text] [Related]  

  • 59. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination.
    Join-Lambert O; Ribadeau-Dumas F; Jullien V; Kitzis MD; Jais JP; Coignard-Biehler H; Guet-Revillet H; Consigny PH; Delage M; Nassif X; Lortholary O; Nassif A
    Eur J Dermatol; 2014; 24(1):94-5. PubMed ID: 24445967
    [No Abstract]   [Full Text] [Related]  

  • 60. A Molecular Perspective on the Potential Benefits of Metformin for the Treatment of Inflammatory Skin Disorders.
    Chang JE; Choi MS
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.